Sep 12, 2022 / 03:05PM GMT
Cecilia E. Furlong - Morgan Stanley, Research Division - Equity Analyst
Good morning, everyone. Again, welcome to the first day of the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst here at Morgan Stanley. And it is my pleasure to have Axonics with us today. Ray Cohen, CEO; and Dan Dearen, CFO.
And before we get started, really quickly, disclosures -- for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. So with that, very happy to have both of you here.
Questions and Answers:
Cecilia E. Furlong - Morgan Stanley, Research Division - Equity AnalystThank you for being here. And would love to just start where I think a lot of conversations these days seem to start on the macro, on the outlook for the back half of this year.
But I think across the board, we hear a lot of med tech companies, especially deferrable procedure companies talking
Trustpilot
